OPHTALMOPHARMA
OphthalmoPharma (OPPH) is a pharmaceutical company specializing in the development of ophthalmology treatments. Their product pipeline addresses major unmet medical needs including dry eye syndrome, glaucoma, and age-related macular degeneration (AMD). Ophthalmopharma has granted Altacor exclusive rights for its two proprietary therapeutic products for the treatment of glaucoma and dry eye as well as exclusive rights for its EyeBar, a nutraceutical for the prevention of dry AMD and the preloaded injector for delivery of intraocular lens in cataract and corrective lens replacement surgery (currently known as SOLO).
OPHTALMOPHARMA
Industry:
Health Care
Founded:
2003-01-01
Address:
Sarnen, Obwalden, Switzerland
Country:
Switzerland
Website Url:
http://www.ophthalmopharma.com
Total Employee:
11+
Status:
Active
Contact:
+41 61 931 46 40
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network 1and1 Website Builder
Similar Organizations
Alcon Pharmaceuticals
Alcon Pharmaceuticals is a medical company specializing in the development of eye care treatments.
Santen Pharmaceutical
Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products.
URL Pharma, Inc.
URL Pharma is a pharmaceuticals company specializing in drug research and development services.
Investors List
Armilar Venture Partners
Armilar Venture Partners investment in Series A - Ophtalmopharma
Official Site Inspections
http://www.ophthalmopharma.com
- Host name: 74-208-236-95.elastic-ssl.ui-r.com
- IP address: 74.208.236.95
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ophtalmopharma"
OphthalmoPharma
Ophthalmopharma has granted Altacor exclusive rights for its two proprietary therapeutic products for the treatment of glaucoma and dry eye as well as exclusive rights for its EyeBar, a …See details»
Ophtalmopharma - Crunchbase Company Profile & Funding
OphthalmoPharma (OPPH) is a pharmaceutical company specializing in the development of ophthalmology treatments. Their product pipeline addresses major unmet medical needs …See details»
OphthalmoPharma Company Profile 2024: Valuation, Funding
OphthalmoPharma General Information Description. Developer of ophthalmic drugs designed to address the unmet medical needs of eye diseases. The company's services are engaged in …See details»
Ophthalmopharma - VentureRadar
Ophthalmopharma is a Swiss-based company, focused on the development of innovative drugs and medical devices for ophthalmology. VentureRadar Research / Company Website. …See details»
OphthalmoPharma - Products, Competitors, Financials, Employees ...
About OphthalmoPharma. OphthalmoPharma is a pharmaceutical company specializing in the development of ophthalmology treatments. The company's main products include treatments …See details»
Ophtalmopharma - Funding, Financials, Valuation & Investors
Jan 1, 2007 OphthalmoPharma (OPPH) is a pharmaceutical company specializing in the development of ophthalmology treatments. Search Crunchbase. Start Free Trial . Chrome …See details»
Ophtalmopharma - CoBee Company Profile & Funding Rounds
OphthalmoPharma (OPPH) is a pharmaceutical company specializing in the development of ophthalmology treatments. Their product pipeline addresses major unmet medical needs …See details»
OphthalmoPharma AG - Drug pipelines, Patents, Clinical trials
Explore OphthalmoPharma AG with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Venture Valuation AG - News - OphthalmoPharma
Geneva, Sept. 24 - Publication No. WO/2010/105678 was published on Sept. 23.According to the abstract posted by the World Intellectual Property Organization: "An injector (1) for folding and …See details»
OphthalmoPharma Management Team - CB Insights
Explore {OphthalmoPharma's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
47 Ophthalmology Companies Worldwide | Biotech Careers
View the directory and locations for 47 biotechnology companies engaged in Ophthalmology work.See details»
Ophthalmopharma | VentureRadar
Ophthalmopharma is a Swiss-based company, focused on the development of innovative drugs and medical devices for ophthalmology. VentureRadar Research / Company Website. …See details»
Labtician Ophthalmics & Théa Pharma - Labtician Ophthalmics
As of January 1, 2023, the 5-year Labtician Théa Joint Venture between Laboratoires Théa and Labtician Ophthalmics has successfully completed.See details»
Ophthamed Pharma Corp. - Online
BECAUSE AT OPHTHAMED PHARMA WE PUT YOUR SAFETY and COMPLETE SATISFACTION ABOVE ALL ELSE in manila. Protecting you and your family is a basic …See details»
List of Top Ophthalmic Pharma Companies - Best Companies
Sep 16, 2024 Conclusion. The world of ophthalmic pharmaceuticals is vibrant, dynamic, and full of innovation. As we’ve seen, the Top Ophthalmic Pharma Companies are not only providing …See details»
VALEO PHARMA PROVIDES UPDATE ON OPHTHALMOLOGY …
Jul 4, 2023 Novartis agrees to sell global rights to XIIDRA® and several other ophthalmology products to Bausch + Lomb SIMBRINZA® not included in the divestiture MONTREAL, …See details»
Big Pharma Loves Ophtho Even More - theophthalmologist.com
Dec 2, 2013 Big Pharma Loves Ophtho Even More. Yet more ophthalmology acquisitions and licensing deals were announced this month… Mark Hillen | 12/02/2013See details»
Clinical trials | Ophthalmology CRO - Iris Pharma
A leading contract research organization (CRO) dedicated to ophthalmic research, Iris Pharma partners with clients to carry out preclinical research and clinical studies involving all areas of …See details»
Contract research services in ophthalmology - Iris Pharma
Thus, Dr. Elena founded Iris Pharma as a contract research organization (CRO) in 1989. Over the years, Iris Pharma has emerged as a worldwide leader in ocular drug and device …See details»
Ophthalmic Solution | Suspension | Ocular Delivery | CDMO
Q&A on Ophthalmic Drug Products: definition, types, ophthalmic formulation considerations, different ocular excipients & more on CDMOs offering formulation development services for …See details»